ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 245 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,731,785 | -45.1% | 114,062 | -56.8% | 0.02% | -40.0% |
| Q1 2023 | $4,971,695 | +2768.0% | 264,171 | +2326.0% | 0.03% | +2900.0% |
| Q4 2022 | $173,353 | -89.7% | 10,889 | -89.4% | 0.00% | -88.9% |
| Q3 2022 | $1,682,000 | +328.0% | 102,825 | +268.9% | 0.01% | +350.0% |
| Q2 2022 | $393,000 | -88.1% | 27,873 | -79.6% | 0.00% | -92.9% |
| Q1 2022 | $3,315,000 | +216.9% | 136,883 | +205.4% | 0.03% | +180.0% |
| Q4 2021 | $1,046,000 | -52.6% | 44,820 | -66.3% | 0.01% | -64.3% |
| Q3 2021 | $2,208,000 | +16.4% | 132,926 | +70.9% | 0.03% | +33.3% |
| Q2 2021 | $1,897,000 | +64.8% | 77,766 | +74.3% | 0.02% | +40.0% |
| Q1 2021 | $1,151,000 | -78.6% | 44,615 | -55.7% | 0.02% | -79.7% |
| Q4 2020 | $5,379,000 | +474.1% | 100,608 | +343.0% | 0.07% | +428.6% |
| Q3 2020 | $937,000 | -92.7% | 22,712 | -91.4% | 0.01% | -93.7% |
| Q2 2020 | $12,856,000 | +750.3% | 265,246 | +650.4% | 0.22% | +692.9% |
| Q4 2019 | $1,512,000 | -56.8% | 35,348 | -63.6% | 0.03% | -59.4% |
| Q3 2019 | $3,497,000 | +1702.6% | 97,176 | +1238.0% | 0.07% | +1625.0% |
| Q2 2019 | $194,000 | -93.9% | 7,263 | -93.9% | 0.00% | -96.1% |
| Q1 2019 | $3,196,000 | +3573.6% | 119,025 | +2113.2% | 0.10% | +2475.0% |
| Q4 2018 | $87,000 | -85.0% | 5,378 | -80.8% | 0.00% | -87.5% |
| Q3 2018 | $580,000 | +28.0% | 27,944 | -5.8% | 0.03% | +39.1% |
| Q2 2018 | $453,000 | +91.1% | 29,655 | +180.8% | 0.02% | +64.3% |
| Q1 2018 | $237,000 | +51.9% | 10,562 | +104.5% | 0.01% | +75.0% |
| Q4 2017 | $156,000 | -56.8% | 5,166 | -46.1% | 0.01% | -60.0% |
| Q3 2017 | $361,000 | +387.8% | 9,578 | +261.6% | 0.02% | +300.0% |
| Q2 2017 | $74,000 | -72.0% | 2,649 | -65.5% | 0.01% | -73.7% |
| Q1 2017 | $264,000 | +37.5% | 7,674 | +15.1% | 0.02% | +26.7% |
| Q4 2016 | $192,000 | +156.0% | 6,667 | +182.4% | 0.02% | +200.0% |
| Q3 2016 | $75,000 | -86.7% | 2,361 | -86.4% | 0.01% | -84.8% |
| Q2 2016 | $563,000 | +223.6% | 17,330 | +178.9% | 0.03% | +230.0% |
| Q1 2016 | $174,000 | -91.4% | 6,214 | -89.1% | 0.01% | -91.6% |
| Q4 2015 | $2,025,000 | -30.5% | 56,816 | -35.5% | 0.12% | -19.0% |
| Q3 2015 | $2,912,000 | +41.9% | 88,058 | +79.7% | 0.15% | +47.0% |
| Q2 2015 | $2,052,000 | +20420.0% | 49,000 | +16233.3% | 0.10% | – |
| Q1 2015 | $10,000 | -81.1% | 300 | -81.9% | 0.00% | -100.0% |
| Q4 2014 | $53,000 | -65.1% | 1,658 | -73.0% | 0.00% | -66.7% |
| Q3 2014 | $152,000 | +36.9% | 6,152 | +25.6% | 0.01% | +28.6% |
| Q2 2014 | $111,000 | – | 4,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |